Philadelphia’s Spark Therapeutics is going through a “fundamental reorganization” by its owner, Swiss pharmaceutical giant Roche, which has written off the regional biotech leader as a financial loss ...

Doylestown Health continues to face financial struggles as it awaits completion of its merger with Penn Medicine, writes John ...

With Monday's news that the Eagles are going to release veteran cornerback Darius Slay, it's possible general manager Howie ...